Note: June 13, 2022 – Nucleus ProVets is aware of the proposed HISA regulations regarding the timelines for use of polyacrylamide hydrogels. To discuss these regulations further please contact our Veterinary Director, Craig T. Roberts, DVM, at craig.roberts@nucleusprovets.com.
Medication rules, a long career span, and frequent competitions mean that the Standardbred racehorse requires the highest level of attention to their joint health. Joint injections should be predictable and planned events, not last-minute problems at a critical time in a racing career. Similarly, unreliable responses to joint therapy are a major source of frustration when a training program is built on dependability.
Initially considered a therapy to use when all else failed, Noltrex®Vet’s dependable results in these impossible situations has led to more veterinarians using it earlier in the management of joint conditions. Adding it to a joint management protocol often minimizes the frequency that other therapies require to reliably maintain an athlete over time.
Hear why veterinarians and owners consider Noltrex®Vet an invaluable tool for managing joint conditions in standardbred racehorses.
Intra-articular (administered into the joint) polyacrylamide hydrogel helped decreased lameness in horses with naturally occurring arthritis, researchers found.
Read MoreThis informative webinar includes: * Understanding the basic progression of osteoarthritis and the differences between therapies to manage it * Why a viscosupplement is so important to successfully manage arthritis * What makes Noltrex®Vet superior to Hyaluronic acids * Use of Noltrex®Vet in severe osteoarthritis * Use of Noltrex®Vet in more routine joint injections for early joint disease management
View NowExplore the clinical applications of Noltrex®Vet and stay up to date on ongoing research